192 related articles for article (PubMed ID: 29878065)
1. Pre-diagnostic Serum Metabolomic Profiling of Prostate Cancer Survival.
Huang J; Weinstein SJ; Moore SC; Derkach A; Hua X; Mondul AM; Sampson JN; Albanes D
J Gerontol A Biol Sci Med Sci; 2019 May; 74(6):853-859. PubMed ID: 29878065
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic profile of prostate cancer-specific survival among 1812 Finnish men.
Huang J; Zhao B; Weinstein SJ; Albanes D; Mondul AM
BMC Med; 2022 Oct; 20(1):362. PubMed ID: 36280842
[TBL] [Abstract][Full Text] [Related]
3. Prospective serum metabolomic profiling of lethal prostate cancer.
Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study.
Mondul AM; Moore SC; Weinstein SJ; Karoly ED; Sampson JN; Albanes D
Int J Cancer; 2015 Nov; 137(9):2124-32. PubMed ID: 25904191
[TBL] [Abstract][Full Text] [Related]
5. Serum Metabolomic Profiling of All-Cause Mortality: A Prospective Analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study Cohort.
Huang J; Weinstein SJ; Moore SC; Derkach A; Hua X; Liao LM; Gu F; Mondul AM; Sampson JN; Albanes D
Am J Epidemiol; 2018 Aug; 187(8):1721-1732. PubMed ID: 29390044
[TBL] [Abstract][Full Text] [Related]
6. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic Profiling of Serum Retinol in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
Huang J; Panagiotou OA; Anic GM; Mondul AM; Liao LM; Derkach A; Stolzenberg-Solomon R; Weinstein SJ; Albanes D
Sci Rep; 2017 Sep; 7(1):10601. PubMed ID: 28878287
[TBL] [Abstract][Full Text] [Related]
8. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
[TBL] [Abstract][Full Text] [Related]
9. Prospective serum metabolomic profile of prostate cancer by size and extent of primary tumor.
Huang J; Mondul AM; Weinstein SJ; Karoly ED; Sampson JN; Albanes D
Oncotarget; 2017 Jul; 8(28):45190-45199. PubMed ID: 28423352
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
Nelson SM; Panagiotou OA; Anic GM; Mondul AM; Männistö S; Weinstein SJ; Albanes D
Int J Epidemiol; 2016 Oct; 45(5):1458-1468. PubMed ID: 27524818
[TBL] [Abstract][Full Text] [Related]
11. Serum β-carotene in relation to risk of prostate cancer: the Kuopio Ischaemic Heart Disease Risk Factor study.
Karppi J; Kurl S; Laukkanen JA; Kauhanen J
Nutr Cancer; 2012 Apr; 64(3):361-7. PubMed ID: 22420939
[TBL] [Abstract][Full Text] [Related]
12. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
13. Untargeted metabolomic profiling identifies serum metabolites associated with type 2 diabetes in a cross-sectional study of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
Liu Y; Gan L; Zhao B; Yu K; Wang Y; Männistö S; Weinstein SJ; Huang J; Albanes D
Am J Physiol Endocrinol Metab; 2023 Feb; 324(2):E167-E175. PubMed ID: 36516224
[TBL] [Abstract][Full Text] [Related]
14. Serum Retinol and Risk of Overall and Site-Specific Cancer in the ATBC Study.
Hada M; Mondul AM; Weinstein SJ; Albanes D
Am J Epidemiol; 2020 Jun; 189(6):532-542. PubMed ID: 31612201
[TBL] [Abstract][Full Text] [Related]
15. Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC.
Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Sieri S; Tumino R; Bueno-de-Mesquita B; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Perez-Cornago A; Assi N; Riboli E; Tsilidis KK; Key TJ; Travis RC
Int J Cancer; 2020 Feb; 146(3):720-730. PubMed ID: 30951192
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic analysis of serum alpha-tocopherol among men in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
Lawrence WR; Lim JE; Huang J; Sampson JN; Weinstein SJ; Albanes D
Eur J Clin Nutr; 2022 Sep; 76(9):1254-1265. PubMed ID: 35322169
[TBL] [Abstract][Full Text] [Related]
17. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study.
Weinstein SJ; Wright ME; Pietinen P; King I; Tan C; Taylor PR; Virtamo J; Albanes D
J Natl Cancer Inst; 2005 Mar; 97(5):396-9. PubMed ID: 15741576
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of detecting prostate cancer by ultraperformance liquid chromatography-mass spectrometry serum metabolomics.
Zang X; Jones CM; Long TQ; Monge ME; Zhou M; Walker LD; Mezencev R; Gray A; McDonald JF; Fernández FM
J Proteome Res; 2014 Jul; 13(7):3444-54. PubMed ID: 24922590
[TBL] [Abstract][Full Text] [Related]
19. Serum and dietary vitamin E in relation to prostate cancer risk.
Weinstein SJ; Wright ME; Lawson KA; Snyder K; Männistö S; Taylor PR; Virtamo J; Albanes D
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1253-9. PubMed ID: 17548693
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D, PTH, and calcium in relation to survival following prostate cancer.
Brändstedt J; Almquist M; Manjer J; Malm J
Cancer Causes Control; 2016 May; 27(5):669-77. PubMed ID: 27023469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
